Leading the way to safer medication
 Crosscheck  Recommender

Insulin (human)

Brand names: ACTRAPHANE ACTRAPID AFREZZA ENTUZITY HUMINSULIN HUMULIN INSULATARD INSUMAN MIXTARD MYXREDLIN NOVOLIN GE PROTAPHANE

Description

The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.

ATC Classification

Code
Title
Category
A10AB01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting
A10AC01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AC Insulins and analogues for injection, intermediate-acting
A10AD01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting
A10AE01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
A10AF01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AF Insulins and analogues for inhalation

Related medicines

MPI, EU: SmPC 2019: ACTRAPID Solution for injection
MPI, EU: SmPC 2019: HUMULIN I Suspension for injection in a vial

3D Molecule Structure

Unique Ingredient Identifier (UNII)

1Y17CTI5SR - INSULIN HUMAN

CAS Registry Number

11061-68-0 - insulin, human

 
Next: Usage >